| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Feb 2026 | 5 Feb 2026 |
| Citurgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve unaudited financial result for the quarter ended on 31.12.2025 UNAUDITED FINANCIAL RESULT FOR THE QUARTER ENDED ON 31.12.2025 (As Per BSE Announcement Dated on:14.02.2026) | ||
| Board Meeting | 23 Dec 2025 | 23 Dec 2025 |
| Appointment of Company Secretary and Compliance Officer The Board of Directors of the Company at has appointed Mr. Aman Patel (A79254) as Company Secretary and Compliance Officer of the Company. (As per BSE Announcement dated on: 23.12.2025) | ||
| Board Meeting | 14 Nov 2025 | 7 Nov 2025 |
| Citurgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Unaudited Financial Results (Standalone) for the quarter and half year ended September 30 2025. UNAUDITED FINANCIAL RESULT FOR THE QUARTER AND HALF YEAR ENDED ON 30.09.2025 (As per BSE Announcement dated on:21.11.2025) | ||
| Board Meeting | 29 Aug 2025 | 26 Aug 2025 |
| Citurgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2025 inter alia to consider and approve dividing of annual general meeting OUTCOME OF BOARD MEETING (As per BSE Announcement Dated on 02/09/2025) | ||
| Board Meeting | 14 Aug 2025 | 11 Aug 2025 |
| Citurgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve Unaudited Financial Results (Standalone) for the quarter ended June 30 2025. Unaudited financial result for Quarter ended 30.06.2025 (As Per BSE Announcement Dated on: 26/08/2025) | ||
| Board Meeting | 30 May 2025 | 24 May 2025 |
| Citurgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve audited financial result for the quarter and year ended on 31.03.2025 AUDITED FINANCIAL RESULT FOR THE QUARTER AND YEAR ENDED ON 31.03.2025 (As Per BSE Announcement Dated on :09.06.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
